CheckMate 9ER: Real World and Health-Related Quality of Life Outcomes

Dr Jonasch shares his perspective on CheckMate 9ER in the real-world setting and discusses the trial’s health-related quality-of-life outcomes data investigating nivolumab plus cabozantinib in advanced renal cell carcinoma treatment.

Related Videos
Experts on renal cell carcinoma
Chandler H. Park, MD, an expert on renal cell carcinoma
Related Content